In Vitro Embryo Production for Cattle Market Report 2026

The in vitro embryo production for cattle market size has grown strongly in recent years. It will grow from $1.1 billion in 2025 to $1.2 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising demand for high productivity dairy and beef cattle breeds, increasing adoption of assisted reproductive technologies in livestock farming, growing awareness of genetic improvement in cattle breeding programs, expansion of veterinary reproductive services infrastructure, increasing government support for livestock productivity enhancement initiatives.

The in vitro embryo production for cattle market size is expected to see strong growth in the next few years. It will grow to $1.74 billion by 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising demand for high genetic merit cattle in dairy and meat industries, increasing adoption of precision breeding and reproductive biotechnology, growing integration of AI and data analytics in livestock reproduction management, expansion of commercial embryo transfer services globally, increasing focus on food security and sustainable livestock production systems. Major trends in the forecast period include increasing adoption of advanced embryo culture media and reagents for improved in vitro fertilization outcomes, rising use of automated oocyte collection and embryo handling systems in cattle breeding programs, growing implementation of genetic screening and embryo selection technologies for high yield livestock, expansion of cryopreservation techniques for long term embryo storage and transport, increasing demand for precision breeding services to enhance dairy and beef cattle productivity.

The rising dairy and meat consumption is expected to propel the growth of the in vitro embryo production for cattle market going forward. Dairy and meat consumption is increasing due to rising income levels, as higher household incomes enable consumers to afford more protein-rich and animal-based food products, which are widely regarded as essential for nutrition and social status. In vitro embryo production (IVP) for cattle supports increased dairy and meat consumption by enhancing cattle reproductive efficiency, enabling farmers to generate a higher number of high-quality calves within shorter timeframes, which results in expanded herd sizes, improved milk productivity, and increased meat availability. For instance, in 2026, according to the World Population Review, a US-based independent organization, global meat consumption has consistently risen, reaching an estimated 453 million tons in 2025, reflecting a 1.5% increase compared to 2024. Therefore, the rising dairy and meat consumption is contributing to and driving the growth of the in vitro embryo production for cattle market.

Leading companies operating in in vitro embryo production for the cattle market are focusing on developing innovative solutions such as ovum pick up (OPU) centers to enhance oocyte collection efficiency, improve embryo yield, and accelerate genetic improvement in cattle. An ovum pick-up (OPU) center refers to a specialized facility where oocytes (eggs) are collected from donor cows using minimally invasive techniques, which are then used for in vitro fertilization and embryo production to improve cattle breeding efficiency. For example, in September 2025, Farmwest, Australia-based leading genetics and reproductive services provider for beef and dairy cattle, opened a state-of-the-art Vytelle ADVANCE IVF satellite facility just outside Bunbury. This new ovum pickup (OPU) center is designed to accelerate genetic improvement by enabling producers to multiply embryos from their highest performing animals without removing them from the herd. It uses hormone-free IVF, allowing producers to collect oocytes from pregnant cows and young animals without additional hormonal treatments, thereby reducing stress and workload.

In September 2025, Trans Ova Genetics, a US-based biotechnology firm, acquired ReproLogix for an undisclosed amount. With this acquisition, Trans Ova Genetics intends to broaden its geographic footprint, strengthen its portfolio of reproductive services, and offer cattle producers wider access to advanced in vitro fertilization and embryo transfer technologies. ReproLogix is a US-based full-service cattle and small ruminant reproduction company that provides in vitro embryo production services for cattle.

Major companies operating in the in vitro embryo production for cattle market are J. R. Simplot Company, Genus plc, Minitube of America Inc., Stroebech Media GmbH, BAIF Development Research Foundation, Semex Alliance, Select Sires Inc., Trans Ova Genetics, URUS Group, Vytelle LLC, IMV Technologies, VikingGenetics A/S, Art Lab Solutions Pvt. Ltd., IVF Bioscience Ltd., Tyndale Vets, Vet Repro Innovations Pvt. Ltd., Embryo Plus, Flying Cow Genetics, Accuvance India Pvt. Ltd., InvitroSul, GenOvations.

North America was the largest region in the in vitro embryo production for cattle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro embryo production for cattle market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the in vitro embryo production for cattle market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro embryo production for the cattle market includes revenues earned by entities by providing services such as oocyte retrieval, in vitro fertilization, embryo culture and development, embryo transfer, cryopreservation, and embryo storage. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.